Court: United States District Court, Eastern District of Pennsylvania

Leadership Position: Plaintiffs’ Executive Comittee

Result: $35 Million

WBE served on the Plaintiffs’ Executive Committee in this case, filed on behalf of purchasers of the allergy drug Flonase (fluticasone propionate).  Plaintiffs alleged that GlaxoSmithKline (“GSK”) filed a series of citizen petitions with the United States Food and Drug Administration (“FDA”) in an improper effort to keep generic versions of Flonase off the market and preserve GSK’s monopoly. WBE recovered a settlement of $35 million.